A Heart of Gold: Better Tissue Repair After Heart Attack

Gold nanowires in engineered patches enhance electrical signaling and contraction

BOSTON, Sept. 25, 2011 /PRNewswire-USNewswire/ -- A team of physicians, engineers and materials scientists at Children's Hospital Boston and the Massachusetts Institute of Technology have used nanotechnology and tiny gold wires to engineer cardiac patches, with cells all beating in time, that could someday help heart attack patients.

As reported online by Nature Nanotechnology on September 25, the addition of gold wires to the engineered heart tissue make it electrically conductive, potentially improving on existing cardiac patches. Such patches are starting to go into clinical trials for heart patients.

"If you don't have the gold nanowires, and you stimulate the cardiac patch with an electrode, the cells will beat only right where you're stimulating," says senior investigator Daniel Kohane, M.D., Ph.D., of the Laboratory for Biomaterials and Drug Delivery at Children's Hospital Boston. "With the nanowires, you see a lot of cells contracting together, even when the stimulation is far away. That shows the tissue is conducting."

After incubation, the patches studded with the gold nanowires were thicker and their heart muscle cells better organized. When stimulated with an electrical current, the cells produced a measurable spike in voltage, and electrical communication between adjacent bundles of cardiac cells was markedly improved. In contrast, only a negligible current passed through patches lacking the wires, and cells beat only in isolated clusters.

Kohane thinks the nanowire technology could be applied to the engineering of any electrically excitable tissue, including tissue in the brain and spinal cord.  Gold was chosen as a material because it's a conductive material, easy to fabricate, scientists have a lot of experience with it, and it is tolerated by the body.

The wires average 30 nanometers thick and 2-3 microns long, just barely visible to the naked eye.

Since testing has so far been done only in cell cultures, the team plans to do further experiments to see how well the cardiac patches function in live animal models, and to get a better understanding of how exactly the nanowires are enhancing electrical signaling and contraction.

Kohane believes the gold fibers help because they're long enough to cross the scaffolding material that holds the cells and may act as a barrier to electrical conduction. In addition, the experiments showed enhanced production of troponin I, a protein involved in muscle calcium binding and contraction, and connexin-43, a protein involved in electrical coupling between cells that is believed to play a critical role in the development of the heart's architecture and in the synchronized contraction of the heart.

The study was funded by the National Institutes of Health and the American Heart Association. The paper's co-first authors were Tal Dvir, Ph.D., and Brian Timko, Ph.D., both of the Department of Chemical Engineering, Massachusetts Institute of Technology, and the Laboratory for Biomaterials and Drug Delivery at Children's Hospital Boston.

Children's Hospital Boston is home to the world's largest research enterprise based at a pediatric medical center, where its discoveries have benefited both children and adults since 1869. More than 1,100 scientists, including nine members of the National Academy of Sciences, 11 members of the Institute of Medicine and nine members of the Howard Hughes Medical Institute comprise Children's research community. Founded as a 20-bed hospital for children, Children's Hospital Boston today is a 396 bed comprehensive center for pediatric and adolescent health care grounded in the values of excellence in patient care and sensitivity to the complex needs and diversity of children and families. Children's also is the primary pediatric teaching affiliate of Harvard Medical School. For more information about research and clinical innovation at Children's, visit: http://vectorblog.org.

CONTACT:
Rob Graham
[email protected]
617-919-3110

SOURCE Children's Hospital Boston